Open AccessRenal dysfunction in patients with radioactive iodine-refractory thyroid cancer treated with tyrosine kinase inhibitors
Author(s) -
H. Iwasaki,
Haruhiko Yamazaki,
Hirotaka Takasaki,
Nobuyasu Suganuma,
Rika Sakai,
Hirotaka Nakayama,
Soji Toda,
Katsuhiko Masudo
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000017588
Subject(s) - lenvatinib , medicine , sorafenib , renal function , thyroid cancer , refractory (planetary science) , adverse effect , tyrosine kinase inhibitor , oncology , gastroenterology , urology , cancer , hepatocellular carcinoma , astrobiology , physics